Sensor100 talks to Jennifer Samproni continued...
S100: Is the day of the clinical lab over, in favour of Point of Care Diagnostics? If
not yet, then when?
JS:Absolutely not. Near-patient testing delivers value, but the extent to which
it compliments centralized laboratory testing (versus having standalone im-
pact) is dictated by several factors.
Near-patient testing which speeds therapeutic decisions and improves
positive patient outcome, improves operational efficiency and streamlines
workflow are the keys to success, and such devices will help to remove some
of the obstacles to adoption of Point of Care (POC) diagnostics.To the ques-
tion of when the balance may shift in favor of POC testing: that rests in the
hands of the medical device manufacturers as they work to bring about these
enabling technologies.
S100: What do you see as the most exciting technical development in sen-
sors in the next 5 -10 years?
JS:The pairing of nanotechnology and flexible electronics have made
for some intriguing applications. Biosensors printed on contact lenses
to monitor tear glucose,“smart tattoos” with biosensors to monitor
metabolic state, wearable sensors to monitor wound healing—we are
just beginning to explore the potential.
S100: What do you do outside the lab? How do you relax?
JS: If you enjoy what you do, can working after work hours be consid-
ered a hobby? I’d say that’s how I spend much of my free time right
now. Insofar as relaxing, I thoroughly enjoy going on day hikes around
New England, especially during the spectacular Fall season.
1...,6,7,8,9,10,11,12,13,14,15 17,18,19,20,21